Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania
- PMID: 19091415
- DOI: 10.1016/j.ophtha.2008.09.011
Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania
Abstract
Objective: Clinically, constant severe trachoma predicts an increased risk of scarring in children. There are no data on the risk of scarring associated with constant infection with Chlamydia trachomatis, regardless of clinical manifestation. We propose to determine the 5-year incidence of scarring in children with a history of constant severe trachoma, constant infection, or both compared with children who had a history of neither.
Design: A 5-year, longitudinal observational study.
Participants: Children aged less than 10 years with data on trachoma and infection for 3 of the 5 visits in the first 18 months, and follow-up 5-year data on scarring.
Methods: Data were collected on clinical trachoma, and ocular swabs were taken to determine the presence of C. trachomatis in children in a hyperendemic village in Tanzania. Images were graded for scarring. Data were collected at baseline; 2, 6, 12, and 18 months; and 5 years from baseline. Severe trachoma was defined as the presence of 10 or more follicles, or trachoma intense. A child had constant infection (severe trachoma) if infection (severe trachoma) was present on at least 3 visits before the 5-year survey.
Main outcome measures: Five-year risk of scarring.
Results: Of the 189 children, 22 (11.6%) had constant severe trachoma, but not constant infection. Nine children (4.8%) had constant infection but not constant severe trachoma. Both constant severe trachoma and constant infection were present in 16 children (8.5%). The 5-year incidence of scarring was similar in all 3 groups; children with constant severe trachoma only, with constant infection only, and with both were most likely to develop scars (35.0%, 44.4%, 31.2%, respectively) compared with those with sporadic trachoma or infection (15.2%) or neither (6.8%) (P = 0.0002).
Conclusions: Children with constant infection are also likely to have constant severe trachoma, and their 5-year risk of scarring is high compared with children with sporadic severe trachoma or infection. These data further support the presence of a subgroup of children who cannot clear infection with C. trachomatis, who may manifest a severe immunologic response to infection, and who are at increased risk of scarring sequelae.
Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.
Similar articles
-
Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1492-7. doi: 10.1167/iovs.06-0625. Invest Ophthalmol Vis Sci. 2007. PMID: 17389476
-
Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area.Invest Ophthalmol Vis Sci. 1993 Oct;34(11):3194-8. Invest Ophthalmol Vis Sci. 1993. PMID: 8407229
-
Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.Invest Ophthalmol Vis Sci. 2006 Jan;47(1):99-104. doi: 10.1167/iovs.05-0326. Invest Ophthalmol Vis Sci. 2006. PMID: 16384950
-
[Isolation of Chlamydia trachomatis in trachomatous Moroccan patients].J Fr Ophtalmol. 1996;19(8-9):527-32. J Fr Ophtalmol. 1996. PMID: 8944135 Review. French.
-
Stopping azithromycin mass drug administration for trachoma: A systematic review.PLoS Negl Trop Dis. 2021 Jul 8;15(7):e0009491. doi: 10.1371/journal.pntd.0009491. eCollection 2021 Jul. PLoS Negl Trop Dis. 2021. PMID: 34237074 Free PMC article.
Cited by
-
The population-based prevalence of trachomatous scarring in a trachoma hyperendemic setting: results from 152 impact surveys in Amhara, Ethiopia.BMC Ophthalmol. 2021 May 13;21(1):213. doi: 10.1186/s12886-021-01972-w. BMC Ophthalmol. 2021. PMID: 33985443 Free PMC article.
-
Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.ScientificWorldJournal. 2013 May 19;2013:648106. doi: 10.1155/2013/648106. Print 2013. ScientificWorldJournal. 2013. PMID: 23766701 Free PMC article. Review.
-
Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma.J Infect. 2020 Apr;80(4):454-461. doi: 10.1016/j.jinf.2020.01.015. Epub 2020 Feb 1. J Infect. 2020. PMID: 32017971 Free PMC article.
-
Using community-based participatory approaches to improve access to mass drug administration for trachoma elimination in a pastoral conflict area of Kenya.PLoS Negl Trop Dis. 2024 Nov 11;18(11):e0012653. doi: 10.1371/journal.pntd.0012653. eCollection 2024 Nov. PLoS Negl Trop Dis. 2024. PMID: 39527600 Free PMC article.
-
Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells.PLoS Negl Trop Dis. 2016 May 24;10(5):e0004734. doi: 10.1371/journal.pntd.0004734. eCollection 2016 May. PLoS Negl Trop Dis. 2016. PMID: 27219121 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical